PENDE, ALDO
 Distribuzione geografica
Continente #
EU - Europa 15.458
AS - Asia 1.625
NA - Nord America 1.326
Continente sconosciuto - Info sul continente non disponibili 283
SA - Sud America 127
AF - Africa 27
OC - Oceania 5
Totale 18.851
Nazione #
IT - Italia 15.175
US - Stati Uniti d'America 1.223
SG - Singapore 665
CN - Cina 408
VN - Vietnam 237
BD - Bangladesh 158
FR - Francia 130
BR - Brasile 73
HK - Hong Kong 67
CA - Canada 47
FI - Finlandia 41
DE - Germania 32
AR - Argentina 25
GB - Regno Unito 19
MX - Messico 16
JP - Giappone 15
CH - Svizzera 14
IN - India 13
NL - Olanda 11
JM - Giamaica 10
IQ - Iraq 9
ID - Indonesia 8
ZA - Sudafrica 8
ES - Italia 7
SA - Arabia Saudita 7
CR - Costa Rica 6
EC - Ecuador 6
HN - Honduras 6
MA - Marocco 6
PK - Pakistan 6
PY - Paraguay 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
RU - Federazione Russa 5
UA - Ucraina 5
CL - Cile 4
PH - Filippine 4
PR - Porto Rico 4
TR - Turchia 4
AT - Austria 3
BB - Barbados 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
JO - Giordania 3
KZ - Kazakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CO - Colombia 2
DZ - Algeria 2
KE - Kenya 2
LB - Libano 2
PL - Polonia 2
SC - Seychelles 2
SE - Svezia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
BZ - Belize 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
GT - Guatemala 1
HT - Haiti 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
LY - Libia 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 18.568
Città #
Genova 9.560
Genoa 3.224
Rapallo 1.218
Vado Ligure 955
San Jose 374
Singapore 329
Ashburn 123
Lauterbourg 123
Ho Chi Minh City 67
Hong Kong 66
Beijing 65
New York 63
Hanoi 59
Bordighera 51
Helsinki 41
Santa Clara 37
Frankfurt am Main 27
Los Angeles 21
Rome 17
Buffalo 16
Haiphong 16
Dallas 14
Milan 14
Zurich 14
Council Bluffs 13
Chicago 12
Tokyo 12
Mexico City 11
Orem 10
Da Nang 9
Guangzhou 9
Tianjin 9
Atlanta 8
Jacksonville 8
Philadelphia 8
Denver 7
Florence 7
Kingston 7
Montreal 7
São Paulo 7
Charlotte 6
Houston 6
Seattle 6
Amsterdam 5
Baghdad 5
Boardman 5
Bologna 5
Can Tho 5
Minneapolis 5
Naples 5
Phoenix 5
San José 5
Tashkent 5
Toledo 5
Toronto 5
Turin 5
Washington 5
Bari 4
Biên Hòa 4
Brooklyn 4
Carlsbad 4
City of London 4
Detroit 4
Johannesburg 4
Kansas City 4
Nha Trang 4
Ocala 4
Palermo 4
Queens 4
San Francisco 4
Shanghai 4
Shenzhen 4
St Louis 4
Ahmedabad 3
Albuquerque 3
Amman 3
Belo Horizonte 3
Bethlehem 3
Bridgetown 3
Carnegie 3
Corona 3
Curitiba 3
Dhaka 3
Fayetteville 3
Jeddah 3
Knoxville 3
Lancaster 3
Marrakesh 3
Miami 3
Mississauga 3
Montesilvano Marina 3
Nuremberg 3
Phủ Lý 3
Poplar 3
Prague 3
Recife 3
Rio de Janeiro 3
San Carlo Canavese 3
San Pedro Sula 3
Surat 3
Totale 16.871
Nome #
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 280
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 228
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 228
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 226
Clorhexidine prevents hypoclorous acid-induced inactivation of alpha1-antitrypsin. 221
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 220
Angiotensin II receptor antagonists in acute coronary syndromes. 220
Prognostic impact of diabetes and prediabetes on survival outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 220
Lipoproteins, stroke and statins. 219
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 219
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 219
Characterization of the binding of the RNA-binding protein AUF1 to the human AT1 receptor mRNA. 199
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 196
Role of Neutrophils in Atherogenesis: an Update 193
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. 191
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 190
Clinical predictors of late SARS-CoV-2 positivity in Italian internal medicine wards 187
Prevalence of erectile dysfunction in a cohort of Italian hypertensive subjects 182
Circadian variations of autologous mixed lymphocyte reactions and endogenous cortisol. 181
Coronary artery calcification and cardiovascular risk: the role of RANKL/OPG signalling. 180
Blunted response of serum aldosterone to metoclopramide in the male elderly 177
Anti-ApoA-1 auto-antibodies increase cardiovascular vulnerability. 177
Serum adiponectin levels predict acute coronary syndrome (ACS) in patients with severe carotid stenosis 177
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 176
Inflammation in the pathophysiology of essential hypertension. 173
Treatment with Angiotensin-(1-7) reduces inflammation in carotid atherosclerotic plaques. 171
Anti-inflammatory approaches to reduce acute cardiovascular events: not only benefits. 171
Plasma dopamine response to sympathetic activation in man: a biphasic pattern. 169
Carotid atherosclerotic plaque stenosis: the stabilizing role of statins. 169
HPLC with electrochemical detection of catecholamines in human plasma, a mini-review. 167
Evidence for interactions between HLA system class I and beta-adrenergic receptors in human mononuclear leukocytes. 167
Carotid ultrasonography in the assessment of cardiovascular risk 167
Anti-apoliprotein A-1 autoantibodies are active mediators of atherosclerotic plaque vulnerability. 167
Agonist-mediated destabilization of human b1-adrenergic receptor mRNA: role of the 3’ untranslated region. 166
Serum PCSK9 levels predict the occurrence of acute coronary syndromes in patients with severe carotid artery stenosis 166
Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis 159
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 158
Neutrophil migration towards C5a and CXCL8 is abrogated by non-steroidal anti-inflammatory drugs (NSAIDs) via the inhibition of different pathways. 158
Cardiovascular prevention: Can we do any better? 158
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy. 154
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence 154
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages 153
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 152
Yohimbine effects on blood pressure and plasma catecholamines in human hypertension 152
Update on the evidence of statin treatment to reduce plaque vulnerability. 150
Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration 149
Morphine-induced TSH release in normal and hypothyroid subjects. 148
Ankle-Brachial Index and cardiovascular events in atrial fibrillation: The ARAPACIS study 147
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects 146
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 144
The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studies. 143
Adrenergic receptors: relevance to myocardial signal transduction in heart failure. 142
Classical and new renin-angiotensin signalling in atherosclerosis. 142
Recombinant tissue plasminogen activator induces neutrophil degranulation activating PI3K/Akt- and ERK1/2-mediated pathways. 142
Inflammation Is a Key Pathophysiological Feature of Metabolic Syndrome. 141
Effects of blood pressure control in cardiovascular prevention 140
Inflammatory cardiovascular risk biomarkers: update on novelties and limitations. 140
Regular Wine Consumption in Chronic Heart Failure: Impact on Outcomes, Quality of Life, and Circulating Biomarkers 139
Editorial: is ischemic stroke an inflammatory disease? 138
Purification and characterization of b-adrenergic receptor mRNA-binding proteins. 138
Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk 137
Prognostic impact of elevated serum uric acid levels on long-term outcomes in patients with chronic heart failure: A post-hoc analysis of the GISSI-HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca-Heart Failure) trial 135
Effects of the H2-receptor antagonist ranitidine on anterior pituitary hormone secretion in man. 133
Epinine kinetics and plasma catecholamine changes following oral administration of the prodrug ibopamine in patients with chronic heart failure. 130
Evaluation of pituitary-thyroid function and prolactin secretion in healthy aged subjects. 130
Troponin elevation does not always mean cardiac ischemia. 130
Regulation of the mRNA-binding protein AUF1 by activation of the b-adrenergic receptor signal transduction pathway. 128
Simultaneous measurement of plasma catecholamine (norepinephrine, epinephrine and dopamine) and free N-methyl dopamine (epinine) levels, by HPLC with electrochemical detection. 128
Characterization of RNA-binding proteins possibly involved in modulating human AT 1 receptor mRNA stability. 127
Alpha-adrenergic control of TSH secretion in man. 125
Correlation between intrinsic mRNA stability and the affinity of AUF1 (hnRNPD) and HuR for A+U-rich mRNAs. 125
Identification and intracellular localization of RNA-binding proteins involved in the modulation of the hAT1 receptor mRNA stability. 123
Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial 123
Preliminary characterization of a transgenic mouse overexpressing the human b1-adrenergic receptor. 122
Effects of rosuvastatin on atrial fibrillation occurrence: Ancillary results of the GISSI-HF trial 122
An inflammatory approach in the therapeutic choices for the prevention of atherosclerotic events 121
The cardiokine secreted Frizzled-related protein 3, a modulator of Wnt signalling, in clinical and experimental heart failure 121
Myocardial-directed overexpression of the human b1-adrenergic receptor in transgenic mice. 120
Differential binding of p37AUF1 to beta-adrenergic receptor mRNAs. 120
Norepinephrine-induced plasma dopamine decrease in man: pharmacological evidence of the involvement of alpha2-adrenoceptors 120
Evidence for adrenergic mediation of the effect of morphine on LH secretion in normal men. 119
Renin-Angiotensin antagonists: therapeutic effects beyond blood pressure control? 119
Is the carotid plaque rupture a pivotal event in stroke pathogenesis? Update on the role of the intraplaque inflammatory processes 118
Reversed-phase HPLC separation of plasma norepinephrine, epinephrine, and dopamine with three-electrode coulimetric detection. 117
Measurement of conjugated catecholamines in human plasma. A low cost HPLC ECD method. 116
Intraindividual variation of beta2-adrenergic receptors on mononuclear leukocytes and their relationships with endogenous plasma catecholamines in man. 116
Regulation of p37AUF1, an mRNA binding protein, in human ventricular myocardium. 115
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 114
Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study 113
Among biomarkers of neutrophil activity, matrix metalloproteinases 8 independently predicts remission of metabolic syndrome 112
Effect of clonidine on gonadotropin secretion in normal men. 112
Neuroendocrine effects of Interferon alpha 2-a in healthy human subjects. 112
Syndrome of inappropriate antidiuretic hormone secretion and Ibuprofen, a rare association to be considered: role of tolvaptan. 111
ß-adrenergic receptor mediated regulation of p37AUF1, an mRNA binding protein, in DDT1-MF2 cells. 111
Interactions between HLA system and beta-adrenergic receptors in human lymphocytes. 110
The 3’ untranslated region of the human beta1-adrenergic receptor is necessary but not sufficient for agonist-mediated destabilization. 110
Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men. 110
Absence of correlations between plasma catecholamine levels and mononuclear leukocyte beta2-adrenergic receptors in the elderly. 110
Evaluation of some aspects of growth hormone regulation in aging. 109
Treatment with oxaprozin reduces neutrophil migration in response to C5a and CXCL8 via the inhibition of the PI3K/Akt pathway. 108
Totale 15.228
Categoria #
all - tutte 57.070
article - articoli 54.223
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.847
Totale 114.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.579 61 97 75 223 70 149 69 368 72 149 57 189
2022/20231.469 144 75 24 162 232 294 2 102 270 4 130 30
2023/2024749 25 128 23 76 66 95 56 81 47 14 36 102
2024/20252.247 61 172 70 134 357 228 200 326 77 114 199 309
2025/20264.069 437 132 252 273 487 405 657 199 245 360 286 336
2026/2027499 499 0 0 0 0 0 0 0 0 0 0 0
Totale 18.851